Want to join the conversation?
$MRK and $PFE said the study will investigate avelumab in combination with INLYTA (axitinib), tyrosine kinase inhibitor (TKI), in patients with previously untreated advanced RCC, and only Phase 3 trial currently evaluating anti-PD-L1 immunotherapy in combination with vascular endothelial growth factor (VEGF)-receptor TKI in this setting.
$CIEN a good stock to look at for the longs. Consistent revenue increase over the past few quarters suggest steady improvement in profitability of the company, which bodes well for the future prospect. I’m going to add a few more to my portfolio, anticipating good $$$ gains !
Shareholder alert..!! Rosen Law Firm has commenced an investigation into potential securities claims of $UHS. Shareholders please visit http://www.rosenlegal.com/cases-1008.html for more info.
Can we see "Made in the USA" label on iPhones in the near future? Heard that $AAPL is considering the idea of manufacturing iPhone in America.
People who are looking for a steady growth stock should take a look at $EME. This stock has never had a significant downfall in the last five years. Comfortably beats consensus target most of the time. Such potential, much wow!
Looks like Creative Planning jumped on the bandwagon! Increased its stake by 91% in $EWBC. A lot of companies recently raised their stack too. I smell something’s cooking.